Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Ginkgo Bioworks Holdings Inc DNA

Alternate Symbol(s):  DNABW

Chemicals Specialty Chemicals
Ginkgo Bioworks Holdings, Inc. operates as a horizontal platform for cell programming, providing end-to-end services for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. Its segments include Cell Engineering and Biosecurity. The Cell Engineering consists of research and development services performed under collaboration... see more

Recent & Breaking News (NYSE:DNA)

Ginkgo Bioworks Update

Newsfile October 31, 2021

Ginkgo Bioworks Shareholder Notice

Newsfile October 29, 2021

Ginkgo Bioworks Shareholder Alert

Newsfile October 28, 2021

Ginkgo Bioworks Previews Today's Annual Ferment Conference

PR Newswire October 28, 2021

Arcaea, a Company Launched on the Ginkgo Bioworks Platform, Announces $78M Series A To Build a New Foundation For the Beauty Industry through Expressive Biology

PR Newswire October 27, 2021

Ginkgo Bioworks Shareholder Alert

Newsfile October 26, 2021

Selecta Biosciences and Ginkgo Bioworks Announce Partnership to Advance Treatments for Orphan and Rare Diseases

GlobeNewswire October 26, 2021

Ginkgo Bioworks Investor Alert

Newsfile October 25, 2021

ONGOING INVESTIGATION REMINDER: The Schall Law Firm Announces It Is Investigating Claims Against Ginkgo Bioworks Holdings, Inc. and Encourages Investors with Losses To Contact the Firm

Newsfile October 25, 2021

Ginkgo Bioworks Shareholder Notice

Newsfile October 24, 2021

Ginkgo Bioworks Shareholder Alert

Newsfile October 22, 2021

Ginkgo Bioworks Investor Alert

Newsfile October 21, 2021

INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Ginkgo Bioworks Holdings, Inc. and Encourages Investors with Losses to Contact the Firm

Newsfile October 21, 2021

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Ginkgo Bioworks Holdings, Inc. and Encourages Investors with Losses to Contact the Firm

Newsfile October 20, 2021

Quest Diagnostics to Provide K-12 School COVID-19 Testing in Collaboration with Ginkgo Bioworks to Support Safer Classroom Learning in Texas for New Statewide School Testing Program

PR Newswire October 20, 2021

Ginkgo Bioworks Announces Participation in Jefferies Gene Therapy/Editing Summit

PR Newswire October 20, 2021

Ginkgo Bioworks Investor Alert

Newsfile October 18, 2021

Ginkgo Bioworks Shareholder Notice

Newsfile October 17, 2021

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ginkgo Bioworks Holdings, Inc. - DNA

PR Newswire October 15, 2021

Ginkgo Bioworks Shareholder Alert

Newsfile October 15, 2021